1-[4-(2,4-Dichlorophenyl)-1,3-thiazol-2-yl]-4-(thiophen-2-yl)-1H-pyrazol-5-amine

Catalog No. :
ACPAZU587
CAS No. :
955965-57-8
Molecular Formula :
C16H10Cl2N4S2
Molecular Weight :
393.32

IUPAC Name:1-(4-(2,4-dichlorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)-1H-pyrazol-5-amine

1-[4-(2,4-Dichlorophenyl)-1,3-thiazol-2-yl]-4-(thiophen-2-yl)-1H-pyrazol-5-amine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$292.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-[4-(2,4-Dichlorophenyl)-1,3-thiazol-2-yl]-4-(thiophen-2-yl)-1H-pyrazol-5-amine
IUPAC Name1-(4-(2,4-dichlorophenyl)thiazol-2-yl)-4-(thiophen-2-yl)-1H-pyrazol-5-amine
MDL No.MFCD03787866
Molecular FormulaC16H10Cl2N4S2
Molecular Weight393.32
SMILESNC1=C(C2=CC=CS2)C=NN1C3=NC(C4=CC=C(Cl)C=C4Cl)=CS3
InChI KeyZIGIMICLZAQPOQ-UHFFFAOYSA-N
Synonym1-[4-(2,4-dichlorophenyl)-1,3-thiazol-2-yl]-4-(thiophen-2-yl)-1H-pyrazol-5-amine;1H-Pyrazol-5-amine, 1-[4-(2,4-dichlorophenyl)-2-thiazolyl]-4-(2-thienyl)-
CAS No.955965-57-8

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACPAZU587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACPYCD326 route compound structure diagram
    ACPYCD3262631-72-3 In Stock
  4. Then
  5. ACPAZU587 route product structure diagram
    ACPAZU587955965-57-8
Inquiry

2. ACPAZU587 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACGYHN540 route compound structure diagram
    ACGYHN54068716-47-2 In Stock
  4. Then
  5. ACPAZU587 route product structure diagram
    ACPAZU587955965-57-8
Inquiry

Comments (0)